Eli Lilly Stock Soars 8% on Q3 Earnings Beat and Raised Guidance to $63.5 Billion on Weight-Loss Drug Boom
Eli Lilly(LLY) shares jumped 8% on October 30, 2025, reaching a new all-time high of $1,012.50 after the pharmaceutical powerhouse reported a stellar third-quarter earnings beat and raised its full-year revenue guidance. The Indianapolis-based drugmaker posted adjusted earnings per share […]










